
Anterix rose 317.1% from $18.35 to $76.53, ahead of the S&P 500's +11.2%. Its worst day was Nov 5 (−11.9%), and its low came Nov 12 at $18.35.
Nov 12, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.47 beat the $-0.62 estimate on $1.6M revenue (est. $1.4M).
+13.7% · S&P 500 −1.7%
EPS of $-0.41 beat the $-0.55 estimate on $1.6M revenue (est. $1.5M).
Story events cover the past 12 months · Times ET
−1.4% · S&P 500 −1.5%
EPS of $0.98 beat the $0.98 estimate on $2.0M revenue (est. $1.6M).
+25.7%, the year's best day · S&P 500 +1.7%
Anterix closed at its highest level of the year, 489.7% above where the year started.
+5.1% · S&P 500 −0.1%
Anterix shares fell 10.8%, while the S&P 500 fell 0.5%.
−10.8% · S&P 500 −0.5%
Anterix shares rose 11.2%, while the S&P 500 rose 1.8%.
+11.2% · S&P 500 +1.8%
EPS of $0.01 beat the $-0.25 estimate on $2.0M revenue (est. $2.0M).
−4.5% · S&P 500 +0.3%
EPS of $-0.25 beat the $-0.32 estimate on $2.0M revenue (est. $2.0M).
+1.4% · S&P 500 +1.3%
Where it ended: a close of $76.53 on Nov 11, 2026. Up next: Q3 2027 earnings on Feb 10, 2027 (EPS est. $-0.27, revenue est. $2.0M).
Nothing in the past 12 months.
All ATEX dividend historyReplay the year: the line draws itself and stops at each of the 8 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for ATEX and SPY from Benzinga historical bars. Not investment advice.